Guten Tag zusammen!

Ich nehme solche Dinge zum Anlass, gerne die original Dokumente herauszuwühlen.
Fangen wir an...

Schritt 1
----------

http://letmegooglethat.com/?q=Biontech+danger+quarterly+investors

Schritt 2
----------
Wir landen hier: https://investors.biontech.de/node/8711/pdf
Das liest man sich bei viel Alkohol durch.
Dann merkt man, da ist so viel nicht zu holen und liest nochmal und genauer.

...are beyond BioNTech’s control and which could cause actual results to
differ materially from those expressed or implied by these forward-looking statements. You should review the risks and uncertainties described under
the heading “Risk Factors” in BioNTech’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (SEC) on March 31,
2020 and in subsequent filings made by BioNTech with the SEC, including the quarterly report for the three and nine months ended September 30,
2020, which are available on the SEC’s website at https://www.sec.gov/

Schritt 3
----------

Man landet hier: https://www.sec.gov/cgi-bin/browse-edgar?CIK=0001776985&action=getcompany

...und ich war erstmal verwirrt. Was ist das alles? Wie ihr merkt, ich habe keinen Schimmer von dieser Materie. Also was macht man? Man liest...und hofft darauf, dadurch besser suchen zu können.
Man klickt sich durch die ersten Dokumente durch und findet

https://www.sec.gov/Archives/edgar/data/1776985/000156459020056932/0001564590-20-056932...

Wir öffnen den darin enthaltenen Link: https://www.sec.gov/Archives/edgar/data/1776985/000156459020056932/bntx-ex992_45.htm

Und lesen nun

IMPORTANT SAFETY INFORMATION:

Do not administer Pfizer BioNTech COVID-19 Vaccine to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the Pfizer BioNTech COVID-19 Vaccine

Appropriate medical treatment used to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of Pfizer BioNTech COVID-19 Vaccine

Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Pfizer BioNTech COVID-19 Vaccine

The Pfizer BioNTech COVID-19 Vaccine may not protect all vaccine recipients

In clinical studies, adverse reactions in participants 16 years of age and older included pain at the injection site (84.1%), fatigue (62.9%), headache (55.1%), muscle pain (38.3%), chills (31.9%), joint pain (23.6%), fever (14.2%), injection site swelling (10.5%), injection site redness (9.5%), nausea (1.1%), malaise (0.5%), and lymphadenopathy (0.3%)

Severe allergic reactions have been reported following the Pfizer-BioNTech COVID-19 Vaccine during mass vaccination outside of clinical trials. Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine

Available data on Pfizer BioNTech COVID-19 Vaccine administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy

Data are not available to assess the effects of Pfizer BioNTech COVID-19 Vaccine on the breastfed infant or on milk production/excretion

There are no data available on the interchangeability of the Pfizer BioNTech COVID 19 Vaccine with other COVID-19 vaccines to complete the vaccination series. Individuals who have received one dose of Pfizer BioNTech COVID-19 Vaccine should receive a second dose of Pfizer BioNTech COVID-19 Vaccine to complete the vaccination series

Ich konnte heute was lernen,ich dachte ich teile das mit euch.

Herzliche Grüße,
QFT